United States Cancer Vaccines Market Research Report Forecast 2017 to 2022

December 2017 | 112 pages | ID: UC889DC731FEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The United States Cancer Vaccines Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Cancer Vaccines industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Cancer Vaccines market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Dendreon
GlaxoSmithKline
Merck
Sanofi
Vaccinogen
Vaxon Biotech
Vical
Aduro BioTech
Advantagene

United States Cancer Vaccines Market: Product Segment Analysis

• Type 1
• Type 2
• Type 3

United States Cancer Vaccines Market: Application Segment Analysis

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 CANCER VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Vaccines
1.2 Cancer Vaccines Market Segmentation by Type
  1.2.1 United States Production Market Share of Cancer Vaccines by Type in 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Cancer Vaccines Market Segmentation by Application
  1.3.1 Cancer Vaccines Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cancer Vaccines (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON CANCER VACCINES INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES CANCER VACCINES MARKET COMPETITION BY MANUFACTURERS

3.1 United States Cancer Vaccines Production and Share by Manufacturers (2015 and 2016)
3.2 United States Cancer Vaccines Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Cancer Vaccines Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Cancer Vaccines Manufacturing Base Distribution, Production Area and Product Type
3.5 Cancer Vaccines Market Competitive Situation and Trends
  3.5.1 Cancer Vaccines Market Concentration Rate
  3.5.2 Cancer Vaccines Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES CANCER VACCINES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Cancer Vaccines Production and Market Share by Type (2012-2017)
4.2 United States Cancer Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Cancer Vaccines Price by Type (2012-2017)
4.4 United States Cancer Vaccines Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES CANCER VACCINES MARKET ANALYSIS BY APPLICATION

5.1 United States Cancer Vaccines Consumption and Market Share by Application (2012-2017)
5.2 United States Cancer Vaccines Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES CANCER VACCINES MANUFACTURERS ANALYSIS

6.1 Dendreon
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 GlaxoSmithKline
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Merck
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Sanofi
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Vaccinogen
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Vaxon Biotech
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Vical
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Aduro BioTech
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Advantagene
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

CHAPTER 7 CANCER VACCINES MANUFACTURING COST ANALYSIS

7.1 Cancer Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Vaccines

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cancer Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES CANCER VACCINES MARKET FORECAST (2017-2022)

11.1 United States Cancer Vaccines Production, Revenue Forecast (2017-2022)
11.2 United States Cancer Vaccines Production, Consumption Forecast by Regions (2017-2022)
11.3 United States Cancer Vaccines Production Forecast by Type (2017-2022)
11.4 United States Cancer Vaccines Consumption Forecast by Application (2017-2022)
11.5 Cancer Vaccines Price Forecast (2017-2022)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGUES

Figure Picture of Cancer Vaccines
Table Classification of Cancer Vaccines
Figure United States Sales Market Share of Cancer Vaccines by Type in 2016
Table Application of Cancer Vaccines
Figure United States Sales Market Share of Cancer Vaccines by Application in 2016
Figure United States Cancer Vaccines Sales and Growth Rate (2011-2021)
Figure United States Cancer Vaccines Revenue and Growth Rate (2011-2021)
Table United States Cancer Vaccines Sales of Key Manufacturers (2015 and 2016)
Table United States Cancer Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Vaccines Sales Share by Manufacturers
Figure 2016 Cancer Vaccines Sales Share by Manufacturers
Table United States Cancer Vaccines Revenue by Manufacturers (2015 and 2016)
Table United States Cancer Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cancer Vaccines Revenue Share by Manufacturers
Table 2016 United States Cancer Vaccines Revenue Share by Manufacturers
Table United States Market Cancer Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cancer Vaccines Average Price of Key Manufacturers in 2015
Figure Cancer Vaccines Market Share of Top 3 Manufacturers
Figure Cancer Vaccines Market Share of Top 5 Manufacturers
Table United States Cancer Vaccines Sales by Type (2012-2017)
Table United States Cancer Vaccines Sales Share by Type (2012-2017)
Figure United States Cancer Vaccines Sales Market Share by Type in 2015
Table United States Cancer Vaccines Revenue and Market Share by Type (2012-2017)
Table United States Cancer Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Vaccines by Type (2012-2017)
Table United States Cancer Vaccines Price by Type (2012-2017)
Figure United States Cancer Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Cancer Vaccines Sales by Application (2012-2017)
Table United States Cancer Vaccines Sales Market Share by Application (2012-2017)
Figure United States Cancer Vaccines Sales Market Share by Application in 2016
Table United States Cancer Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Cancer Vaccines Sales Growth Rate by Application (2012-2017)
Table Dendreon Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Dendreon Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Dendreon Cancer Vaccines Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Cancer Vaccines Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Cancer Vaccines Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Cancer Vaccines Market Share (2012-2017)
Table Vaccinogen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Vaccinogen Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Vaccinogen Cancer Vaccines Market Share (2012-2017)
Table Vaxon Biotech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Vaxon Biotech Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Vaxon Biotech Cancer Vaccines Market Share (2012-2017)
Table Vical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Vical Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Vical Cancer Vaccines Market Share (2012-2017)
Table Aduro BioTech Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Aduro BioTech Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Aduro BioTech Cancer Vaccines Market Share (2012-2017)
Table Advantagene Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Advantagene Cancer Vaccines Production, Revenue, Price and Gross Margin (2012-2017)
Table Advantagene Cancer Vaccines Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Vaccines
Figure Manufacturing Process Analysis of Cancer Vaccines
Figure Cancer Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2016
Table Major Buyers of Cancer Vaccines
Table Distributors/Traders List
Figure United States Cancer Vaccines Production and Growth Rate Forecast (2017-2022)
Figure United States Cancer Vaccines Revenue and Growth Rate Forecast (2017-2022)
Table United States Cancer Vaccines Production Forecast by Type (2017-2022)
Table United States Cancer Vaccines Consumption Forecast by Application (2017-2022)